Amneal Pharmaceuticals, Inc.
NYSE:AMRX
Overview | Financials
Company Name | Amneal Pharmaceuticals, Inc. |
Symbol | AMRX |
Currency | USD |
Price | 7.78 |
Market Cap | 3,594,056,697 |
Dividend Yield | 0% |
52-week-range | 5.01 - 9.475 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Chirag K. Patel |
Website | https://www.amneal.com |
An error occurred while fetching data.
About Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD